Colonial River Investments’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$754K Sell
1,503
-252
-14% -$121K 0.21% 90
2026
Q1
$862K Buy
1,755
+40
+2% +$21.7K 0.31% 72
2025
Q4
$993K Buy
1,715
+3
+0.2% +$1.7K 0.35% 63
2025
Q3
$830K Buy
1,712
+55
+3% +$25.6K 0.31% 77
2025
Q2
$714K Buy
1,657
+479
+41% +$200K 0.31% 71
2025
Q1
$586K Buy
+1,178
New +$638K 0.32% 74
2022
Q1
Sell
-346
Closed -$231K 232
2021
Q4
$231K Buy
+346
New +$216K 0.12% 195

Other funds holding TMO

Colonial River Investments's TMO Position: Q2 2026 in Review

Colonial River Investments reduced its Thermo Fisher Scientific (TMO) stake by 14% in Q2 2026, selling an estimated $121K and leaving 1,503 shares worth $754K. The position accounts for 0.21% of the portfolio, ranked #90.

Colonial River Investments first reported a position in TMO in Q4 2021 and has held it in 7 quarters since. The position peaked at $993K in Q4 2025. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Colonial River Investments held 1,503 shares of Thermo Fisher Scientific worth $754K as of Q2 2026.
  • Colonial River Investments sold 252 Thermo Fisher Scientific shares in Q2 2026, an estimated $121K.
  • Thermo Fisher Scientific made up 0.21% of Colonial River Investments's portfolio in Q2 2026, its #90 holding.
  • Colonial River Investments first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 7 quarters since.
  • Colonial River Investments's Thermo Fisher Scientific position peaked at $993K in Q4 2025.
  • 1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Colonial River Investments's 13F filing for Q2 2026, filed 24 Jul 2026.